1 – 10 of 53
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor
- 2016
- Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
- Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
- 2015
- Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.
- TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
- The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.
- Targeting of nucleotide-binding proteins by HAMLET-a conserved tumor cell death mechanism.
- 2014
- The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner.
- 2013
- Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.
- MiR-155-mediated loss of C/EBP beta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer